, FNP Exam 3: Women’s Health Practice Questions
1. The North American Menopause Society (NAMS) cur- D
rent position on the use of HT in menopausal women
includes:
A. HT is indicated for the sole purpose of preventing
cardiovascular disease
B. ET for less than 5 years has significant effect on the
risk for breast cancer
C. HT is recommended for prevention of cognitive
aging or dementia
D. EPT is recommended to decrease risk of endometri-
al carcinoma.
2. What types of estrogen are usually present in a wom- A
ans body in the postmenopausal years?
A. Estrone (E1) and estradiol (E2)
B. Estrone (E1) and estriol (E3)
C. Estradiol (E2) only
D. None; women do not produce estrogen after
menopause
3. In general, natural menopause occurs for most C
women between the ages of years.
A. 40 and 50
B. 44 and 46
C. 48 and 55
D. 39 and 47
4. Which of the following statements about menopause A
is false?
, FNP Exam 3: Women’s Health Practice Questions
A. A diagnosis is based on the absence of menses for
6 consecutive months.
B. Controlling diabetes and hypertension can reduce
the severity of symptoms.
C. Similar symptoms may be caused by arrhythmia,
thyroid disorders, or tumors.
D. Diagnosis requires a thorough history, a physical
exam, and lab testing.
5. Which of the following statement about menopause is C
true?
A. Symptoms usually begin in the postmenopausal
period
B. Women most frequently report CNS symptoms
C. Hot flashes can last well beyond the first 5-7 years
following menopause
D. Women typically experience the most severe symp-
toms during perimenopause
6. Among the midlife health issues of women, the num- B
ber one cause of mortality in the US is?
A. Primary osteoporosis
B. Cardiovascular disease
C. Overweight and obesity
D. Cancer (of the lung and bronchus, breast and colon)
7. Lifestyle approaches to postmenopausal symptoms B
management include:
A. Sleeping more than 8 hours per nights
B. Avoiding sugar, coffee, chocolate, and alcohol
, FNP Exam 3: Women’s Health Practice Questions
C. Decreasing levels of physical activity
D. More than 1,000 international units/day of vitamin
E
8. The standard for managing moderate to sever D
menopausal symptoms is:
A. Lifestyle changes, such as diet and exercising
B. Non-hormone products, such as anticonvulsive
medications
C. Alternate care, such as acupunture, combined with
organic herbs
D. Prescription systemic hormone products, such as
estrogen and progesterone
9. When HT is prescribed for relief of the vasomotor A
symptoms of menopause, patients should:
A. Find that their symptoms begin to resolve within 2-6
weeks
B. Be told that they ought not to experience side ef-
fects if they follow direction.
C. Return for follow up with the clinician within one
year after the initial dose
D. Initially be given ET or EPT at higher than standard
doses
10. The use of complementary and alternative medicines C
(CAM)
A. By women is on the downturn in the US
B. Is usually reported to the patient's primary care
clinician